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according to the nonparametric Wilcoxon–Mann–Whitney test
(p < 0.05) with Benjamini and Hochberg adjustment for p-values.
Over one third of these compounds were identified only in the
malignant ascites. The major significant differences between the
malignant and control ascites were observed for fatty acids and
their derivatives, which are known to be among the key compo-
nents of intercellular signaling.
In summary this study extended our knowledge of the protein
and metabolomic composition of the ovarian cancer ascites and
revealed its specific features which were associated with the func-
tion of the ascitic fluid as a medium of interaction between the
malignant cells and their environment.
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Members of the transforming growth factor (TGF)-signaling
pathway are common targets for mutation in colon cancers.
Deregulation of this pathway appears to play an important role
in colon carcinogenesis by affecting TGF-mediated growth inhi-
bition, apoptosis, and differentiation as well as other TGF-regu-
lated processes. In particular, inactivating mutations of the TGF-
ß-receptor type II (TGFBR2) occur in more than 90% of micro-
satellite unstable (MSI) colon cancers. In order to systematically
analyze TGFBR2-deficiency-associated changes of the biochemi-
cal phenotype of MSI colon carcinoma cells we used the
TGFBR2-deficient MSI colon carcinoma cell line HCT116 as a
model system. Stable clones conferring doxycycline (dox)-induc-
ible expression of a single copy wild type TGFBR2 transgene
were generated by recombinase-mediated cassette exchange
(RCME). By applying a click-chemistry approach with azido-
derivatized amino-acids or monosaccharides we specifically
labeled newly synthesized proteins or post-translational glycan
modifications after dox-induction as well as in uninduced cells
and clicked a biotin residue to the metabolically labeled proteins
or oligosaccharide chains. Finally we extracted the labeled pro-
teins by streptavidine-coupled magnetic beads. Identification of
the bound proteins was achieved by nano-HPLC-coupled Orbi-
trap mass spectrometry. A total of 76 proteins was found to be
expressed in a TGFBR2-dependent manner: 40 individual pro-
teins were only expressed in TGFBR2-deficient cells and 36 indi-
vidual proteins were exclusively found in TGFBR2-proficient
cells. For 19 proteins altered sialylation and for 21 proteins
altered fucosylation was found.
Altogether this study, based on a combination of three tech-
nologies, i.e. RCME, click-chemistry and mass spectrometry, pro-
vides a versatile platform to analyze proteomic as well as
posttranslational modifications caused by MSI-relevant target
genes like TGFBR2. On the one hand this approach can help to
systematically puzzle out the consequences of tumor-specific
mutations in a major signalling pathway as exemplified by the
TFGBR2 tumor suppressor, on the other hand this approach
facilitates the identification of tumor markers that could be used
for diagnostic and therapeutic applications.
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Introduction: Apoptosis is a highly orchestrated, genetically reg-
ulated form of cell death, the impairment of which is crucial in
breast cancer (BC) development and progression. BCL2L12, a
member of the BCL2 family of apoptosis-related genes, has been
studied in various malignancies, revealing its potential role as a
tumor biomarker. It has been recently found that BCL2L12 is
subjected to alternative splicing, resulting in the generation of 13
alternatively spliced variants. The aim of this study was the
quantification of BCL2L12 splice variants 1 and 2 (v.1 and v.2)
expression at the mRNA level and the assessment of their bio-
marker potential in BC.
Methods: Total RNA was extracted from 40 pairs of BC and nor-
mal tissues. Thereafter, RNA was reverse transcribed into first-
strand cDNA, which in turn was used as template in a SYBRGreen
based Real-Time PCR assay. Relative quantification analysis was
conducted using the comparative CT (2
ddC
T) method, and the
associations of BCL2L12 variants expression with various clino-
pathological parameters, were evaluated by statistical analysis.
Results: BCL2L12 v.1 mRNA levels were found to be signifi-
cantly (p = 0.003) higher in malignant compared to their
matched non-cancerous breast tissues. Moreover, BCL2L12 v.1
demonstrated increased expression in premenopausal women
(p = 0.026) as well as in those with early TNM stage tumors
(p = 0.039). Interestingly, significant BCL2L12 v.1 upregulation
(p = 0.044) was observed in triple negative BC. Regarding
BCL2L12 v.2, a negative correlation with patients’ age was found
((rs = 0.376; p = 0.017), whereas increased BCL2L12 v.2 expres-
sion levels were associated with advanced tumor grade
(p = 0.022) and ER-negativity (p = 0.01).
Conclusion: Our preliminary results indicate a possible involve-
ment of BCL2L12 v.1 and v.2 in BC progression and suggest
their potential as biomarker in this malignancy.
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Signal Transducer and Activator of Transcription 3 (STAT3) is a
transcription factor that is essential for embryogenesis and is
involved in the development and maintenance of several tissues,
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